| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| Credit Suisse | 16.19 | 16.22 | 16.08 | +0.07 | +0.47% | 9.40M | 20/04 | ||
| Adecco | 69.20 | 69.86 | 68.92 | -0.38 | -0.55% | 970.15K | 20/04 | ||
| Richemont | 92.88 | 93.86 | 92.38 | -0.58 | -0.62% | 1.58M | 20/04 | ||
| Julius Baer | 58.50 | 58.70 | 57.96 | +0.32 | +0.55% | 843.31K | 20/04 | ||
| ABB | 23.68 | 23.93 | 23.63 | +0.08 | +0.34% | 9.85M | 20/04 | ||
| LafargeHolcim | 55.34 | 55.64 | 55.02 | +0.26 | +0.47% | 1.72M | 20/04 | ||
| Zurich Insurance Group | 313.70 | 314.20 | 310.90 | +0.90 | +0.29% | 1.48M | 20/04 | ||
| Swatch I | 467.10 | 468.20 | 460.00 | +6.70 | +1.46% | 235.21K | 20/04 | ||
| Swiss Life Holding | 356.70 | 357.70 | 354.90 | +0.80 | +0.22% | 178.09K | 20/04 | ||
| Novartis | 76.08 | 77.14 | 75.92 | -1.20 | -1.55% | 8.44M | 20/04 | ||
| Nestle | 75.20 | 75.30 | 74.74 | -0.20 | -0.27% | 15.85M | 20/04 | ||
| Swiss Re | 97.56 | 97.80 | 97.04 | +0.50 | +0.52% | 2.63M | 20/04 | ||
| Roche Holding Participation | 215.65 | 217.25 | 215.40 | -0.85 | -0.39% | 1.83M | 20/04 | ||
| Lonza Group | 245.00 | 245.80 | 243.60 | -0.30 | -0.12% | 402.00K | 20/04 | ||
| Swisscom | 462.90 | 463.90 | 455.70 | +6.60 | +1.45% | 190.35K | 20/04 | ||
| SGS | 2,416.00 | 2,436.00 | 2,402.00 | -10.00 | -0.41% | 25.45K | 20/04 | ||
| Geberit | 429.60 | 430.70 | 427.70 | +0.30 | +0.07% | 136.93K | 20/04 | ||
| Sika I | 7,340.00 | 7,450.00 | 7,305.00 | -85.00 | -1.14% | 6.77K | 20/04 | ||
| UBS Group | 17.20 | 17.29 | 17.13 | +0.08 | +0.47% | 19.46M | 20/04 | ||
| Givaudan | 2,204.00 | 2,209.00 | 2,190.00 | +5.00 | +0.23% | 43.36K | 20/04 |
By Lewis Krauskopf NEW YORK (Reuters) - The potential for an intensifying trade dispute to undercut the U.S. stock market could become clearer next week when a host of...
By Martinne Geller and Richa Naidu LONDON/CHICAGO (Reuters) - Procter & Gamble's $4.2 billion deal for Merck's vitamin and supplements business is the latest example...
By Andrew Berlin NEW YORK (LPC) - Regulated banks are underwriting more highly leveraged buyout loans for US companies as the Republican administration relaxes guidelines aimed at...
This week was ruled by cancer data presentations by drug companies at the annual meeting of the American Association for Cancer Research (AACR) in Chicago. Other than that, J&J (NYSE:JNJ) and...
UBS Group AG (NYSE:UBS) is scheduled to report first-quarter 2018 results on Apr 27. Results might benefit from equity market rally and improved business sentiments during the quarter. However, a...
Bristol-Myers Squibb Company (NYSE:BMY) announced that the FDA has accepted and granted a priority review designation to the supplemental Biologics License Application (sBLA) for the label expansion...
